跳转至内容
Merck

O3639

Sigma-Aldrich

昂丹司琼 盐酸盐 二水合物

≥98% (HPLC), powder, 5-HT₃serotonin receptor antagonist

别名:

1,2,3,9-四氢-9-甲基-3-[(2-甲基-1H-咪唑-1-基)甲基] -4H-咔唑-4-酮 盐酸盐, GR 38032F

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C18H19N3O · HCl · 2H2O
分子量:
365.85
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.32

product name

昂丹司琼 盐酸盐 二水合物, ≥98% (HPLC), powder

化驗

≥98% (HPLC)

形狀

powder

儲存條件

desiccated

顏色

white

溶解度

H2O: >5 mg/mL

儲存溫度

−20°C

SMILES 字串

Cl[H].[H]O[H].[H]O[H].Cc1nccn1CC2CCc3c(C2=O)c4ccccc4n3C

InChI

1S/C18H19N3O.ClH.2H2O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2;;;/h3-6,9-10,13H,7-8,11H2,1-2H3;1H;2*1H2

InChI 密鑰

VRSLTNZJOUZKLX-UHFFFAOYSA-N

基因資訊

human ... HTR3A(3359)

正在寻找类似产品? 访问 产品对比指南

應用

恩丹西酮盐酸盐二水合物已用作 5-HT3 拮抗剂,用于减弱 延髓吻段腹内侧部(RVM)/缩胆囊素(CCK)诱导的机械超敏反应,并用于阻断曲古抑菌素 A(TSA)对 5-HT3 蛋白的作用。

生化/生理作用

昂丹司琼,(3RS)-9-甲基-3-[(2-甲基-1H-咪唑-1-基)甲基] 1,2,3,9-四氢-4H-咔唑-4-酮盐酸盐脱水剂作为选择性 5-羟色胺 3 型(5-HT3)5-羟色胺受体拮抗剂。它被用作止吐剂,控制与化疗和放疗相关的恶心和呕吐。
5-HT3 血清素受体拮抗剂

特點和優勢

该化合物由 GlaxoSmithKline 开发。想要浏览其他由制药公司开发的化合物以及已批准药物/候选药物清单,请单击此处

訊號詞

Danger

危險聲明

危險分類

Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 2 - Eye Dam. 1

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Global experience with ondansetron and future potential.
Butcher ME
Oncology, 50(3), 191-197 (1993)
Aruna Sharma et al.
Molecular neurobiology, 52(2), 867-881 (2015-07-03)
Military personnel are often subjected to sleep deprivation (SD) during combat operations. Since SD is a severe stress and alters neurochemical metabolism in the brain, a possibility exists that acute or long-term SD will influence blood-brain barrier (BBB) function and
Alcohol-induced serotonergic modulation: the role of histone deacetylases
Agudelo M
Alcohol, 46(7), 635-642 (2012)
ION-PAIR REVERSED-PHASE HIGHPERFORMANCE
LIQUID CHROMATOGRAPHY
OF ONDANSETRON HYDROCHLORIDE USING
SODIUM HEPTANESULPHONATE AS A
COUNTERION
varvara A
Farmacia, 57, 4, 442-451 (2009)
J H Ye et al.
CNS drug reviews, 7(2), 199-213 (2001-07-28)
Ondansetron is a selective 5-hydroxytryptamine(3) (5-HT(3)) receptor antagonist that has been introduced to clinical practice as an antiemetic for cancer treatment-induced and anesthesia-related nausea and vomiting. Its use under these circumstances is both prophylactic and therapeutic. It has a superior

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门